| Entry |
|
|---|
| Name |
Pargyline (INN) |
|---|
| Formula |
C11H13N
|
|---|
| Exact mass |
159.1048
|
|---|
| Mol weight |
159.2276
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidepressant, Antihypertensive, Monoamine oxidase (MAO) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07216 | Catecholamine transferase inhibitors |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02K OTHER ANTIHYPERTENSIVES
C02KC MAO inhibitors
C02KC01 Pargyline
D08453 Pargyline (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00264 Pargyline
D08453 Pargyline
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Amine oxidases
MAO
D08453 Pargyline (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00264 Pargyline
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 12
1 C8y C 24.5000 -17.6400
2 C1b C 25.6900 -16.9400
3 C8x C 24.5000 -19.0400
4 C8x C 23.3100 -16.9400
5 N1c N 26.9500 -17.6400
6 C8x C 23.3100 -19.7400
7 C8x C 22.1200 -17.6400
8 C1b C 28.1400 -16.9400
9 C1a C 26.9500 -19.0400
10 C8x C 22.1200 -19.0400
11 C3b C 29.3300 -17.6400
12 C3a C 30.5900 -18.3400
BOND 12
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 1
8 5 9 1
9 6 10 1
10 8 11 1
11 11 12 3
12 7 10 2
|
|---|
